0.012706
0.000000
0.006117
0.000000
0.015492
0.000000
0.000000
0.000000
0.028316
0.00000
0.00000
0.00000
Anand, K.
Mesters, J.R.
Goerlach, R.
Zell, R.
Hilgenfeld, R.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
4
90.00
115.71
90.00
78.706
64.550
39.196
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
Cl -1
35.453
CHLORIDE ION
non-polymer
C5 H11 N O3 S2
197.276
n
S,S-(2-HYDROXYETHYL)THIOCYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
To be Published
0353
Crystal Structure of Coxsackie Virus B3 Proteinase 3C
UK
RNA
RNARFU
2122
1355-8382
8
188
10.1017/S1355838202012785
11911365
Determinants of the Recognition of Enteroviral Cloverleaf RNA by Coxsackievirus B3 Proteinase 3C.
2002
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
100
1
MIRRORS
CCD
2003-10-23
MARRESEARCH
SINGLE WAVELENGTH
M
x-ray
1
0.804
1.0
X13
EMBL/DESY, HAMBURG
0.804
SYNCHROTRON
EMBL/DESY, HAMBURG BEAMLINE X13
BETA-MERCAPTOETHANOL LINKED TO ACTIVE-SITE CYSTEINE
20374.410
POLYPROTEIN 3BCD
3.4.22.28
3C PROTEINASE, RESIDUES 14-196
1
man
polymer
35.453
CHLORIDE ION
1
syn
non-polymer
18.015
water
47
nat
water
COXSACKIEVIRUS B3 PROTEINASE 3C
no
yes
GPAFEFAVAMMKRNSSTVKTEYGEFTMLGIYDRWAVLPRHAKPGPTILMNDQEVGVLDAKELVDKDGTNLELTLLKLNRN
EKFRDIRGFLAKEEVEVNEAVLAINTSKFPNMYIPVGQVTEYGFLNLGGTPTKRMLMYNFPTRAGQ(CME)GGVLMSTGK
VLGIHVGGNGHQGFSAALLKHYFNDEQ
GPAFEFAVAMMKRNSSTVKTEYGEFTMLGIYDRWAVLPRHAKPGPTILMNDQEVGVLDAKELVDKDGTNLELTLLKLNRN
EKFRDIRGFLAKEEVEVNEAVLAINTSKFPNMYIPVGQVTEYGFLNLGGTPTKRMLMYNFPTRAGQCGGVLMSTGKVLGI
HVGGNGHQGFSAALLKHYFNDEQ
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
NANCY
sample
103903
COXSACKIEVIRUS B3
511693
ESCHERICHIA COLI
BL21
PET23A-3CSTOP
1
2.17
42.85
NONE
5.5
pH 5.5
diffrn_source
pdbx_unobs_or_zero_occ_atoms
struct_conn
repository
Initial release
Source and taxonomy
Version format compliance
Advisory
Data collection
Derived calculations
1
0
2008-10-28
1
1
2011-07-13
1
2
2019-07-24
_diffrn_source.pdbx_synchrotron_site
_struct_conn.pdbx_leaving_atom_flag
SHEET
DETERMINATION METHOD: DSSP
THE SHEETS PRESENTED AS "AA" IN EACH CHAIN ON SHEET RECORDS
BELOW IS ACTUALLY AN 7-STRANDED BARREL THIS IS REPRESENTED BY
A 8-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS
ARE IDENTICAL.
THE SHEETS PRESENTED AS "AB" IN EACH CHAIN ON SHEET RECORDS
BELOW IS ACTUALLY AN 7-STRANDED BARREL THIS IS REPRESENTED BY
A 8-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS
ARE IDENTICAL.
PDBE
Y
PDBE
2007-09-05
REL
CL
CHLORIDE ION
HOH
water
CL
1184
2
CL
CL
1184
A
HOH
2001
3
HOH
HOH
2001
A
HOH
2002
3
HOH
HOH
2002
A
HOH
2003
3
HOH
HOH
2003
A
HOH
2004
3
HOH
HOH
2004
A
HOH
2005
3
HOH
HOH
2005
A
HOH
2006
3
HOH
HOH
2006
A
HOH
2007
3
HOH
HOH
2007
A
HOH
2008
3
HOH
HOH
2008
A
HOH
2009
3
HOH
HOH
2009
A
HOH
2010
3
HOH
HOH
2010
A
HOH
2011
3
HOH
HOH
2011
A
HOH
2012
3
HOH
HOH
2012
A
HOH
2013
3
HOH
HOH
2013
A
HOH
2014
3
HOH
HOH
2014
A
HOH
2015
3
HOH
HOH
2015
A
HOH
2016
3
HOH
HOH
2016
A
HOH
2017
3
HOH
HOH
2017
A
HOH
2018
3
HOH
HOH
2018
A
HOH
2019
3
HOH
HOH
2019
A
HOH
2020
3
HOH
HOH
2020
A
HOH
2021
3
HOH
HOH
2021
A
HOH
2022
3
HOH
HOH
2022
A
HOH
2023
3
HOH
HOH
2023
A
HOH
2024
3
HOH
HOH
2024
A
HOH
2025
3
HOH
HOH
2025
A
HOH
2026
3
HOH
HOH
2026
A
HOH
2027
3
HOH
HOH
2027
A
HOH
2028
3
HOH
HOH
2028
A
HOH
2029
3
HOH
HOH
2029
A
HOH
2030
3
HOH
HOH
2030
A
HOH
2031
3
HOH
HOH
2031
A
HOH
2032
3
HOH
HOH
2032
A
HOH
2033
3
HOH
HOH
2033
A
HOH
2034
3
HOH
HOH
2034
A
HOH
2035
3
HOH
HOH
2035
A
HOH
2036
3
HOH
HOH
2036
A
HOH
2037
3
HOH
HOH
2037
A
HOH
2038
3
HOH
HOH
2038
A
HOH
2039
3
HOH
HOH
2039
A
HOH
2040
3
HOH
HOH
2040
A
HOH
2041
3
HOH
HOH
2041
A
HOH
2042
3
HOH
HOH
2042
A
HOH
2043
3
HOH
HOH
2043
A
HOH
2044
3
HOH
HOH
2044
A
HOH
2045
3
HOH
HOH
2045
A
HOH
2046
3
HOH
HOH
2046
A
HOH
2047
3
HOH
HOH
2047
A
GLY
1
n
1
GLY
1
A
PRO
2
n
2
PRO
2
A
ALA
3
n
3
ALA
3
A
PHE
4
n
4
PHE
4
A
GLU
5
n
5
GLU
5
A
PHE
6
n
6
PHE
6
A
ALA
7
n
7
ALA
7
A
VAL
8
n
8
VAL
8
A
ALA
9
n
9
ALA
9
A
MET
10
n
10
MET
10
A
MET
11
n
11
MET
11
A
LYS
12
n
12
LYS
12
A
ARG
13
n
13
ARG
13
A
ASN
14
n
14
ASN
14
A
SER
15
n
15
SER
15
A
SER
16
n
16
SER
16
A
THR
17
n
17
THR
17
A
VAL
18
n
18
VAL
18
A
LYS
19
n
19
LYS
19
A
THR
20
n
20
THR
20
A
GLU
21
n
21
GLU
21
A
TYR
22
n
22
TYR
22
A
GLY
23
n
23
GLY
23
A
GLU
24
n
24
GLU
24
A
PHE
25
n
25
PHE
25
A
THR
26
n
26
THR
26
A
MET
27
n
27
MET
27
A
LEU
28
n
28
LEU
28
A
GLY
29
n
29
GLY
29
A
ILE
30
n
30
ILE
30
A
TYR
31
n
31
TYR
31
A
ASP
32
n
32
ASP
32
A
ARG
33
n
33
ARG
33
A
TRP
34
n
34
TRP
34
A
ALA
35
n
35
ALA
35
A
VAL
36
n
36
VAL
36
A
LEU
37
n
37
LEU
37
A
PRO
38
n
38
PRO
38
A
ARG
39
n
39
ARG
39
A
HIS
40
n
40
HIS
40
A
ALA
41
n
41
ALA
41
A
LYS
42
n
42
LYS
42
A
PRO
43
n
43
PRO
43
A
GLY
44
n
44
GLY
44
A
PRO
45
n
45
PRO
45
A
THR
46
n
46
THR
46
A
ILE
47
n
47
ILE
47
A
LEU
48
n
48
LEU
48
A
MET
49
n
49
MET
49
A
ASN
50
n
50
ASN
50
A
ASP
51
n
51
ASP
51
A
GLN
52
n
52
GLN
52
A
GLU
53
n
53
GLU
53
A
VAL
54
n
54
VAL
54
A
GLY
55
n
55
GLY
55
A
VAL
56
n
56
VAL
56
A
LEU
57
n
57
LEU
57
A
ASP
58
n
58
ASP
58
A
ALA
59
n
59
ALA
59
A
LYS
60
n
60
LYS
60
A
GLU
61
n
61
GLU
61
A
LEU
62
n
62
LEU
62
A
VAL
63
n
63
VAL
63
A
ASP
64
n
64
ASP
64
A
LYS
65
n
65
LYS
65
A
ASP
66
n
66
ASP
66
A
GLY
67
n
67
GLY
67
A
THR
68
n
68
THR
68
A
ASN
69
n
69
ASN
69
A
LEU
70
n
70
LEU
70
A
GLU
71
n
71
GLU
71
A
LEU
72
n
72
LEU
72
A
THR
73
n
73
THR
73
A
LEU
74
n
74
LEU
74
A
LEU
75
n
75
LEU
75
A
LYS
76
n
76
LYS
76
A
LEU
77
n
77
LEU
77
A
ASN
78
n
78
ASN
78
A
ARG
79
n
79
ARG
79
A
ASN
80
n
80
ASN
80
A
GLU
81
n
81
GLU
81
A
LYS
82
n
82
LYS
82
A
PHE
83
n
83
PHE
83
A
ARG
84
n
84
ARG
84
A
ASP
85
n
85
ASP
85
A
ILE
86
n
86
ILE
86
A
ARG
87
n
87
ARG
87
A
GLY
88
n
88
GLY
88
A
PHE
89
n
89
PHE
89
A
LEU
90
n
90
LEU
90
A
ALA
91
n
91
ALA
91
A
LYS
92
n
92
LYS
92
A
GLU
93
n
93
GLU
93
A
GLU
94
n
94
GLU
94
A
VAL
95
n
95
VAL
95
A
GLU
96
n
96
GLU
96
A
VAL
97
n
97
VAL
97
A
ASN
98
n
98
ASN
98
A
GLU
99
n
99
GLU
99
A
ALA
100
n
100
ALA
100
A
VAL
101
n
101
VAL
101
A
LEU
102
n
102
LEU
102
A
ALA
103
n
103
ALA
103
A
ILE
104
n
104
ILE
104
A
ASN
105
n
105
ASN
105
A
THR
106
n
106
THR
106
A
SER
107
n
107
SER
107
A
LYS
108
n
108
LYS
108
A
PHE
109
n
109
PHE
109
A
PRO
110
n
110
PRO
110
A
ASN
111
n
111
ASN
111
A
MET
112
n
112
MET
112
A
TYR
113
n
113
TYR
113
A
ILE
114
n
114
ILE
114
A
PRO
115
n
115
PRO
115
A
VAL
116
n
116
VAL
116
A
GLY
117
n
117
GLY
117
A
GLN
118
n
118
GLN
118
A
VAL
119
n
119
VAL
119
A
THR
120
n
120
THR
120
A
GLU
121
n
121
GLU
121
A
TYR
122
n
122
TYR
122
A
GLY
123
n
123
GLY
123
A
PHE
124
n
124
PHE
124
A
LEU
125
n
125
LEU
125
A
ASN
126
n
126
ASN
126
A
LEU
127
n
127
LEU
127
A
GLY
128
n
128
GLY
128
A
GLY
129
n
129
GLY
129
A
THR
130
n
130
THR
130
A
PRO
131
n
131
PRO
131
A
THR
132
n
132
THR
132
A
LYS
133
n
133
LYS
133
A
ARG
134
n
134
ARG
134
A
MET
135
n
135
MET
135
A
LEU
136
n
136
LEU
136
A
MET
137
n
137
MET
137
A
TYR
138
n
138
TYR
138
A
ASN
139
n
139
ASN
139
A
PHE
140
n
140
PHE
140
A
PRO
141
n
141
PRO
141
A
THR
142
n
142
THR
142
A
ARG
143
n
143
ARG
143
A
ALA
144
n
144
ALA
144
A
GLY
145
n
145
GLY
145
A
GLN
146
n
146
GLN
146
A
CME
147
n
147
CME
147
A
GLY
148
n
148
GLY
148
A
GLY
149
n
149
GLY
149
A
VAL
150
n
150
VAL
150
A
LEU
151
n
151
LEU
151
A
MET
152
n
152
MET
152
A
SER
153
n
153
SER
153
A
THR
154
n
154
THR
154
A
GLY
155
n
155
GLY
155
A
LYS
156
n
156
LYS
156
A
VAL
157
n
157
VAL
157
A
LEU
158
n
158
LEU
158
A
GLY
159
n
159
GLY
159
A
ILE
160
n
160
ILE
160
A
HIS
161
n
161
HIS
161
A
VAL
162
n
162
VAL
162
A
GLY
163
n
163
GLY
163
A
GLY
164
n
164
GLY
164
A
ASN
165
n
165
ASN
165
A
GLY
166
n
166
GLY
166
A
HIS
167
n
167
HIS
167
A
GLN
168
n
168
GLN
168
A
GLY
169
n
169
GLY
169
A
PHE
170
n
170
PHE
170
A
SER
171
n
171
SER
171
A
ALA
172
n
172
ALA
172
A
ALA
173
n
173
ALA
173
A
LEU
174
n
174
LEU
174
A
LEU
175
n
175
LEU
175
A
LYS
176
n
176
LYS
176
A
HIS
177
n
177
HIS
177
A
TYR
178
n
178
TYR
178
A
PHE
179
n
179
PHE
179
A
ASN
180
n
180
ASN
180
A
ASP
181
n
181
ASP
181
A
GLU
182
n
182
GLU
182
A
GLN
183
n
183
GLN
183
A
author_and_software_defined_assembly
PQS
2
dimeric
1510
-16.0
20120
A
CME
147
S,S-(2-HYDROXYETHYL)THIOCYSTEINE
A
CME
147
CYS
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
2_555
-x,y,-z
crystal symmetry operation
0.0000000000
0.0000000000
0.0000000000
A
N
THR
20
A
N
THR
20
A
O
GLY
23
A
O
GLY
23
A
N
ILE
30
A
N
ILE
30
A
O
TRP
34
A
O
TRP
34
A
N
LEU
37
A
N
LEU
37
A
O
THR
73
A
O
THR
73
A
N
ASN
78
A
N
ASN
78
A
O
GLY
55
A
O
GLY
55
A
N
VAL
54
A
N
VAL
54
A
O
ILE
47
A
O
ILE
47
A
N
LEU
48
A
N
LEU
48
A
O
LYS
19
A
O
LYS
19
A
N
ILE
104
A
N
ILE
104
A
O
MET
112
A
O
MET
112
A
N
LEU
127
A
N
LEU
127
A
O
THR
130
A
O
THR
130
A
N
TYR
138
A
N
TYR
138
A
O
GLY
169
A
O
GLY
169
A
N
ALA
172
A
N
ALA
172
A
O
ILE
160
A
O
ILE
160
A
N
LEU
158
A
N
LEU
158
A
O
LEU
151
A
O
LEU
151
A
N
MET
152
A
N
MET
152
A
O
VAL
101
A
O
VAL
101
1
A
A
NE2
SD
HIS
CME
40
147
2.19
1
-22.05
1.50
103.20
81.15
A
A
A
N
CD
CG
PRO
PRO
PRO
2
2
2
N
1
19.88
2.60
111.60
131.48
A
A
A
CB
CG
CD
LYS
LYS
LYS
60
60
60
N
1
14.26
2.30
115.30
129.56
A
A
A
CA
CB
CG
LEU
LEU
LEU
75
75
75
N
1
3.04
0.50
120.30
123.34
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
79
79
79
N
1
-3.30
0.50
120.30
117.00
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
79
79
79
N
1
-12.00
2.00
110.40
98.40
A
A
A
CB
CA
C
LYS
LYS
LYS
108
108
108
N
1
21.85
1.80
110.60
132.45
A
A
A
N
CA
CB
LYS
LYS
LYS
108
108
108
N
1
A
A
CG
CD
PRO
PRO
2
2
0.249
0.033
1.502
1.751
N
1
A
A
CD
N
PRO
PRO
2
2
0.358
0.014
1.474
1.832
N
1
A
ASP
32
51.66
-109.79
1
A
LYS
42
36.53
57.98
1
A
ASP
51
53.75
15.35
1
A
THR
106
-107.19
-158.12
1
A
ASN
111
36.58
63.53
1
A
GLU
121
-65.35
94.41
1
A
PRO
141
-54.57
94.25
1
A
ARG
143
-170.42
147.45
1
A
SER
153
-129.73
-167.54
1
A
ASP
181
-34.48
105.03
1
A
GLU
182
64.40
-133.74
47.96
0.27000
0.00000
-0.25000
-0.30000
0.00000
-0.19000
0.938
0.896
HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS.
0.266
0.207
0.210
2.40
35.36
330
6582
4.800
99.1
9.986
0.244
RANDOM
1
THROUGHOUT
MOLECULAR REPLACEMENT
0.715
0.307
0.80
0.80
1.20
HAV 3CPRO
MAXIMUM LIKELIHOOD
BABINET MODEL WITH MASK
2.40
35.36
47
1477
1
0
1429
0.017
0.022
1447
1.837
1.969
1954
8.337
5.000
182
36.931
24.394
66
19.531
15.000
243
18.069
15.000
8
0.124
0.200
213
0.007
0.020
1104
0.237
0.200
633
0.314
0.200
935
0.192
0.200
83
0.222
0.200
32
0.227
0.200
3
0.937
1.500
931
1.568
2.000
1444
2.216
3.000
584
3.044
4.500
510
0.3230
0.2420
2.46
26
427
20
2.40
35.36
2VB0
6931
-3.0
0.11
1
11.95
5.1
99.7
0.40
2.40
2.46
4.00
1
97.4
refinement
REFMAC
5.3.0037
data reduction
DENZO
data scaling
SCALEPACK
phasing
EPMR
POLYPROTEIN 3BCD (E.C.3.4.22.28)
Crystal structure of coxsackievirus B3 proteinase 3C
1
N
N
2
N
N
3
N
N
A
GLY
1
A
GLY
1
HELX_P
A
ASN
14
A
ASN
14
1
1
14
A
HIS
40
A
HIS
40
HELX_P
A
LYS
42
A
LYS
42
5
2
3
A
ILE
86
A
ILE
86
HELX_P
A
LEU
90
A
LEU
90
5
3
5
A
LEU
175
A
LEU
175
HELX_P
A
ASN
180
A
ASN
180
5
4
6
covale
1.337
both
A
GLN
146
A
C
GLN
146
1_555
A
CME
147
A
N
CME
147
1_555
covale
1.326
both
A
CME
147
A
C
CME
147
1_555
A
GLY
148
A
N
GLY
148
1_555
HYDROLASE
CHYMOTRYPSIN-LIKE FOLD, AG7088, RNA-BINDING PROTEIN, PICORNAVIRIDAE, CYSTEINE PROTEASE, HUMAN ENTEROVIRUS B, HYDROLASE
Q90092_9ENTO
UNP
1
Q90092
14
196
2VB0
1
183
Q90092
A
1
1
183
8
8
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
SER
15
A
SER
15
A
THR
20
A
THR
20
A
GLY
23
A
GLY
23
A
TYR
31
A
TYR
31
A
TRP
34
A
TRP
34
A
PRO
38
A
PRO
38
A
ASN
69
A
ASN
69
A
ASN
78
A
ASN
78
A
GLU
53
A
GLU
53
A
VAL
63
A
VAL
63
A
THR
46
A
THR
46
A
MET
49
A
MET
49
A
SER
15
A
SER
15
A
THR
20
A
THR
20
A
SER
15
A
SER
15
A
THR
20
A
THR
20
A
VAL
97
A
VAL
97
A
ILE
104
A
ILE
104
A
MET
112
A
MET
112
A
LEU
127
A
LEU
127
A
THR
130
A
THR
130
A
ASN
139
A
ASN
139
A
GLN
168
A
GLN
168
A
ALA
173
A
ALA
173
A
LYS
156
A
LYS
156
A
GLY
164
A
GLY
164
A
VAL
150
A
VAL
150
A
SER
153
A
SER
153
A
VAL
97
A
VAL
97
A
ILE
104
A
ILE
104
A
VAL
97
A
VAL
97
A
ILE
104
A
ILE
104
BINDING SITE FOR RESIDUE CL A1184
Software
4
A
ASP
85
A
ASP
85
4
1_555
A
ILE
86
A
ILE
86
4
1_555
A
ARG
87
A
ARG
87
4
1_555
A
GLY
88
A
GLY
88
4
1_555
5
C 1 2 1